Determinants of syncytium formation in microglia by human immunodeficiency virus type 1.: Role of the V1/V2 domains

被引:47
作者
Shieh, JTC
Martín, J
Baltuch, G
Malim, MH
González-Scarano, F
机构
[1] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurosurg, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Dept Microbiol, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/JVI.74.2.693-701.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Microglia are the main reservoir for human immunodeficiency virus type 1 (HIV-1) in the central nervous system (CNS), and multinucleated giant cells, the result of fusion of HIV-1-infected microglia and brain macrophages, are the neuropathologic hallmark of HIV dementia. One potential explanation for the formation of syncytia is viral adaptation for these CD4(+) CNS cells. HIV-1(BORI-15), a virus adapted to growth in microglia by sequential passage in vitro, mediates high levels of fusion and replicates more efficiently in microglia and monocyte-derived-macrophages than its unpassaged parent (J. M. Strizki, A. V. Albright, H. Sheng, M. O'Connor, L. Perrin, and F. Gonzalez-Scarano, J. Virol. 70:7654-7662, 1996). Since the interaction between the viral envelope glycoprotein and CD4 and the chemokine receptor mediates fusion and plays a key role in tropism, we have analyzed the HIV-1(BORI-15) env as a fusogen and in recombinant and pseudotyped viruses. Its syncytium-forming phenotype is not the result of a switch in coreceptor use but rather of the HIV-1(BORI-15) envelope-mediated fusion of CD4(+)CCR5(+) cells with greater efficiency than that of its parental strain, either by itself or in the context of a recombinant virus. Genetic analysis indicated that the syncytium-forming phenotype was due to four discrete amino acid differences in V1/V2, with a single-amino-acid change between the parent and the adapted virus (E153G) responsible for the majority of the effect. Additionally, HIV-1(BORI-15) env-pseudotyped viruses were less sensitive to decreases in the levels of CD4 on transfected 293T cells, leading to the hypothesis that the differences in V1/V2 alter the interaction between this envelope and CD4 or CCR5, or both. In sum, the characterization of the envelope of HIV-1(BORI-15) a highly fusogenic glycoprotein with genetic determinants in V1/V2, may lead to a better understanding of the relationship between HIV replication and syncytium formation in the CNS and of the importance of this region of gp120 in the interaction with CD4 and CCR5.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 76 条
[31]   Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein [J].
Hoffman, TL ;
LaBranche, CC ;
Zhang, WT ;
Canziani, G ;
Robinson, J ;
Chaiken, I ;
Hoxie, JA ;
Doms, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6359-6364
[32]   HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors [J].
Hoffman, TL ;
Stephens, EB ;
Narayan, O ;
Doms, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11360-11365
[33]   IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1 [J].
HWANG, SS ;
BOYLE, TJ ;
LYERLY, HK ;
CULLEN, BR .
SCIENCE, 1991, 253 (5015) :71-74
[34]  
IOANNIDIS JPA, 1995, AM J PATHOL, V147, P1200
[35]   V3 SEQUENCES OF PAIRED HIV-1 ISOLATES FROM BLOOD AND CEREBROSPINAL-FLUID CLUSTER ACCORDING TO HOST AND SHOW VARIATION RELATED TO THE CLINICAL STAGE OF DISEASE [J].
KEYS, B ;
KARIS, J ;
FADEEL, B ;
VALENTIN, A ;
NORKRANS, G ;
HAGBERG, L ;
CHIODI, F .
VIROLOGY, 1993, 196 (02) :475-483
[36]   FUNCTIONAL-ROLE OF THE V1/V2 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 IN INFECTION OF PRIMARY MACROPHAGES AND SOLUBLE CD4 NEUTRALIZATION [J].
KOITO, A ;
HARROWE, G ;
LEVY, JA ;
CHENGMAYER, C .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2253-2259
[37]   GENETIC-DIFFERENCES BETWEEN BLOOD-DERIVED AND BRAIN-DERIVED VIRAL SEQUENCES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS - EVIDENCE OF CONSERVED ELEMENTS IN THE V3-REGION OF THE ENVELOPE PROTEIN OF BRAIN-DERIVED SEQUENCES [J].
KORBER, BTM ;
KUNSTMAN, KJ ;
PATTERSON, BK ;
FURTADO, M ;
MCEVILLY, MM ;
LEVY, R ;
WOLINSKY, SM .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7467-7481
[38]   DUAL INFECTION OF THE CENTRAL-NERVOUS-SYSTEM BY AIDS VIRUSES WITH DISTINCT CELLULAR TROPISMS [J].
KOYANAGI, Y ;
MILES, S ;
MITSUYASU, RT ;
MERRILL, JE ;
VINTERS, HV ;
CHEN, ISY .
SCIENCE, 1987, 236 (4803) :819-822
[39]   CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 [J].
Kozak, SL ;
Platt, EJ ;
Madani, N ;
Ferro, FE ;
Peden, K ;
Kabat, D .
JOURNAL OF VIROLOGY, 1997, 71 (02) :873-882
[40]   RETRACTED: Fusion-competent vaccines broad neutralization of primary isolates of HIV (Retracted article. See vol 296, pg 1025, 2002) [J].
LaCasse, RA ;
Follis, KE ;
Trahey, M ;
Scarborough, JD ;
Littman, DR ;
Nunberg, JH .
SCIENCE, 1999, 283 (5400) :357-362